ADVM - Adverum Biotechnologies - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ADVM is currently covered by 5 analysts with an average price target of $5.05. This is a potential upside of $-0.99 (-16.39%) from yesterday's end of day stock price of $6.04.

Adverum Biotechnologies's activity chart (see below) currently has 48 price targets and 53 ratings on display. The stock rating distribution of ADVM is 84.62% BUY and 15.38% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 52.96% with an average time for these price targets to be met of 135.83 days.

Highest price target for ADVM is $40, Lowest price target is $10, average price target is $5.05.

Most recent stock forecast was given by LUCA ISSI from RBC on 05-Nov-2024. First documented stock forecast 25-Aug-2014.

Currently out of the existing stock ratings of ADVM, 11 are a BUY (84.62%), 2 are a HOLD (15.38%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$10

$3.14 (45.77%)

$12

17 days ago
(05-Nov-2024)

1/6 (16.67%)

$2.39 (31.41%)

35

Buy

$30

$23.14 (337.32%)

$30

3 months 9 days ago
(13-Aug-2024)

0/3 (0%)

$23.24 (343.79%)

Buy

$40

$33.14 (483.09%)

$4

4 months 4 days ago
(18-Jul-2024)

1/4 (25%)

$30.52 (321.94%)

543

Buy

$22

$15.14 (220.70%)

$40

6 months 24 days ago
(29-Apr-2024)

2/5 (40%)

$12.47 (130.85%)

52

Buy

$6

$4.05 (207.69%)

$4

1 years 2 months 18 days ago
(05-Sep-2023)

4/7 (57.14%)

$4.22 (237.08%)

196

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ADVM (Adverum Biotechnologies) average time for price targets to be met?

On average it took 135.83 days on average for the stock forecasts to be realized with a an average price target met ratio 52.96

Which analyst has the current highest performing score on ADVM (Adverum Biotechnologies) with a proven track record?

ALETHIA YOUNG

Which analyst has the most public recommendations on ADVM (Adverum Biotechnologies)?

Alethia Young works at CANTOR FITZGERALD and has 9 price targets and 6 ratings on ADVM

Which analyst is the currently most bullish on ADVM (Adverum Biotechnologies)?

Biren Amin with highest potential upside - $44.14

Which analyst is the currently most reserved on ADVM (Adverum Biotechnologies)?

Tyler Van Buren with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?